Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹74.7 Cr 3.1% -10% -59.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,400.1 Cr -3% -9% -15.1% Stock Analytics
KIRI INDUSTRIES ₹3,630.8 Cr 6.3% 4.5% -4.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,723.9 Cr 1.1% -5.2% -38.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,230.3 Cr 0.8% -6.7% 20.8% Stock Analytics
BODAL CHEMICALS ₹673.8 Cr 1.3% -1.6% -22.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

3.1%

-10%

-59.8%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses